Impact of Teacher Training and the Introduction of Early Adjustments on the Developmental Trajectory of Children at Risk of SLLD in Pre-school.

NCT ID: NCT06062147

Last Updated: 2025-06-13

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

165 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-09-22

Study Completion Date

2024-06-24

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The high incidence of neurodevelopmental disorders, including specific language and learning disorders, and their profund impact on the schooling of the children concerned remains a major public health concern. Early identification and intervention are a valuable tool for improving these problems. The developmental trajectory of children could be improved by knowledge enhancement, identification and strategies to support the teachers through the involvement of health professionals in the classroom

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

PRISME - TSLA is a clinical trial developing experiment project for the intervention arm involving teacher training, the implementation of identification grids, follow-up observations in classroom of identified pupils, and the development of special arrangments. For the control arm, the teachers work with standard procedures of the French national education policy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Language Disorders in Children Learning; Developmental Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Pragmatic cluster controlled trial (quasi-experimental design)
Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

teacher training

Teacher training and support for teachers in setting up specific arrangements.

Group Type EXPERIMENTAL

Teacher training

Intervention Type BEHAVIORAL

Training for teachers in the intervention arm in the learning process, SLLD and early warning signs, with an identification grid. Observation of identified pupils and implementation of educational and environmental adjustments.

control class

Teacher will proceed in the usual way, referring to the procedures put in place by the national education system for identifying and referring children at risk

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Teacher training

Training for teachers in the intervention arm in the learning process, SLLD and early warning signs, with an identification grid. Observation of identified pupils and implementation of educational and environmental adjustments.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Pupils :

* In a kindergarten school with at least 3 classes of primary school age children.
* At least 5 years old on 31/12/2023.
* Whose 2 parents have given their consent (the consent of a single parent if no contact is possible with the second parent despite repeated attempts)
* Have received age-appropriate explanations about the study and have not refused to take part.

Exclusion Criteria

Pupils in :

* In a kindergarten school with fewer than 3 classes, making it impossible to randomise the school
* Under 5 years of age on 31 December of the current school year.
* Under guardianship
Minimum Eligible Age

5 Years

Maximum Eligible Age

6 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Centre Hospitalier Universitaire de la Réunion

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Magali CARBONNNIER, MD

Role: PRINCIPAL_INVESTIGATOR

Fondation Père FAVRON

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

CHU de La Réunion

Saint-Denis, , Reunion

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Reunion

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023-A01501-44

Identifier Type: OTHER

Identifier Source: secondary_id

2023/CHU/28

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.